The BioEscalator, Oxford University's Biotech incubator, provides lab space and entrepreneurial support for high growth startups.
Oxford’s Old Road Campus is home to many of the University’s world-class institutes and departments, with 8500 staff and students tackling the full range of medical health challenges across the world. The BioEscalator builds on this success by nurturing early-stage biotech companies through to sustainability, by facilitating collaboration with NHS and academics, to build a community of entrepreneurial medical scientists and innovators.
Our focus is on getting more discoveries out of the lab and into patient care by providing fully equipped shared facilities allowing your company to start innovating from the moment you move in.
Connecting startups to cutting-edge laboratory facilities in Oxford
18 May 2023
The BioEscalator and Oxford University Innovation teamed up to hold an event to showcase the state-of-the-art laboratory facilities at the University of Oxford to resident BioEscalator companies and start-ups from the Oxfordshire innovation ecosystem.
Oxford Cancer Analytics raises $3.7M led by Eka Ventures to revolutionise liquid biopsy and early cancer detection
10 January 2023
Oxford Cancer Analytics is pioneering a new generation of blood-based liquid biopsy tests for early cancer detection. It has announced the completion of an additional seed financing round, led by Eka Ventures, with participation from LifeArc, MegaRobo Technologies, Oxford Technology Management, and value-add individual investors. The Oxford and Toronto-based company has raised $5.5M to date. It will invest in expanding its first-in-class international studies and developing products for the deadliest cancers that can benefit most from liquid biopsy early detection.
Oxford Cancer Analytics part of Oxford team that aims to detect lung cancer early via a simple blood test
16 December 2022
A team of Oxford scientists and clinicians has launched a study to detect the early stages of lung cancer using a blood test and machine learning. The team from Oxford University Hospitals (OUH) NHS Foundation Trust, the Oxford Radcliffe Biobank and the local spin-out company Oxford Cancer Analytics (OXcan) will recruit 200 participants to identify cancer biomarkers - molecules such as proteins found in blood that are a sign of lung cancer. Oxford Cancer analytics joined the BioEscalator community in June 2022.
BioEscalator Bulletin no.6
BioEscalator Innovation Building,
University of Oxford,
Old Road Campus,